Back
Genelux Corp. 10K Form
Sell
19
GNLX
Genelux Corp.
Last Price:
$4.52
Seasonality Move:
25.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GNLX News And Ratings
See the #1 stock for the next 7 days that we like better than GNLX
GNLX Financial Statistics
Sales & Book Value
| Annual Sales: | $8K |
|---|---|
| Cash Flow: | $-7.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.49 |
| Price / Book: | 8.94 |
Profitability
| EPS (TTM): | -0.87930 |
|---|---|
| Net Income (TTM): | $-31.9M |
| Gross Margin: | $-895K |
| Return on Equity: | -121.01% |
| Return on Assets: | -93.09% |
Genelux Corp. Earnings Forecast
Key Genelux Corp. Financial Ratios
-
The Gross Profit Margin over the past 6 years for GNLX is -11,187.50%.
-
The Selling, General & Administrative Expenses for GNLX have been equal to 158,825.00% of Gross Profit Margin.
-
The Research & Development expenses have been 237,475.00% of Revenue.
-
The Net Earning history of GNLX is -373,362.50% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 2 years.
Genelux Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GNLX |
| Website: | genelux.com |
Debt
| Debt-to-Equity Ratio: | 0.09 |
|---|---|
| Current Ratio: | 4.2 |
| Quick Ratio: | 4.08 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
GNLX Technical Analysis vs Fundamental Analysis
Sell
19
Genelux Corp. (GNLX)
is a Sell
Is Genelux Corp. a Buy or a Sell?
-
Genelux Corp. stock is rated a SellThe current Genelux Corp. [GNLX] share price is $4.37. The Score for GNLX is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.